Amalgamated Bank’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,662
| Closed | -$9K | – | 2549 |
|
|
2025
Q4 | $9K | Buy |
2,662
+5
| +0.2% | +$17 | ﹤0.01% | 2486 |
|
|
2025
Q3 | $9K | Hold |
2,657
| – | – | ﹤0.01% | 2527 |
|
|
2025
Q2 | $7K | Hold |
2,657
| – | – | ﹤0.01% | 2602 |
|
|
2025
Q1 | $18K | Buy |
2,657
+517
| +24% | +$5.11K | ﹤0.01% | 2104 |
|
|
2024
Q4 | $27K | Hold |
2,140
| – | – | ﹤0.01% | 2018 |
|
|
2024
Q3 | $40K | Hold |
2,140
| – | – | ﹤0.01% | 1907 |
|
|
2024
Q2 | $46K | Hold |
2,140
| – | – | ﹤0.01% | 1870 |
|
|
2024
Q1 | $58K | Sell |
2,140
-6,513
| -75% | -$185K | ﹤0.01% | 1829 |
|
|
2023
Q4 | $259K | Buy |
8,653
+440
| +5% | +$9.71K | ﹤0.01% | 1717 |
|
|
2023
Q3 | $168K | Hold |
8,213
| – | – | ﹤0.01% | 1841 |
|
|
2023
Q2 | $163K | Buy |
8,213
+2,434
| +42% | +$49.2K | ﹤0.01% | 1897 |
|
|
2023
Q1 | $99K | Sell |
5,779
-1,285
| -18% | -$25.2K | ﹤0.01% | 2064 |
|
|
2022
Q4 | $138K | Buy |
7,064
+1,503
| +27% | +$27.7K | ﹤0.01% | 1997 |
|
|
2022
Q3 | $89K | Hold |
5,561
| – | – | ﹤0.01% | 2204 |
|
|
2022
Q2 | $77K | Sell |
5,561
-1,150
| -17% | -$13.7K | ﹤0.01% | 2286 |
|
|
2022
Q1 | $106K | Buy |
+6,711
| New | +$116K | ﹤0.01% | 2175 |
|
|
2021
Q4 | – | Sell |
-7,238
| Closed | -$216K | – | 2174 |
|
|
2021
Q3 | $216K | Sell |
7,238
-264
| -4% | -$9.61K | ﹤0.01% | 1967 |
|
|
2021
Q2 | $332K | Buy |
7,502
+2,179
| +41% | +$94.6K | ﹤0.01% | 1838 |
|
|
2021
Q1 | $236K | Buy |
5,323
+1
| +0% | +$55 | 0.01% | 1396 |
|
|
2020
Q4 | $292K | Buy |
+5,322
| New | +$194K | 0.01% | 1240 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
